Asensus Surgical, Inc. (NYSE American: ASXC), a medical device
company that is digitizing the interface between the surgeon and
the patient to pioneer a new era of Performance-Guided Surgery™, is
providing this corporate update in conjunction with its previously
announced Investor Day, which will be hosted today, beginning at
11:30am EST.
“Our vision is to revolutionize the way surgery is performed and
ultimately the way patients are treated. To date, we have made
tremendous progress evolving robotically-assisted surgery into
Digital Laparoscopy with the combination of our Senhance® Surgical
System and the intelligent capabilities of our Intelligent Surgical
Unit™(ISU™). However, we expect more from a surgical solution,”
said Anthony Fernando, President and Chief Executive Officer of
Asensus. “We have first hand knowledge, shaped by thousands of
real-world procedures and years of interactions with surgeons and
hospitals, of what the market needs, which is much more than just a
robot. The best solution will materially reduce surgical
variability and deliver improved outcomes. We are working to
deliver that solution, a new era of surgery called
Performance-Guided Surgery, the foundation of which will be our new
LUNA™ Surgical System and the clinical intelligence capabilities
provided to surgeons through the ongoing development of the
ISU.”
Based on its clinical and commercial experience to date, the
Company is introducing an integrated Digital Surgery solution
comprising a next generation surgical platform and instruments,
real-time intraoperative clinical intelligence and a secure cloud
platform to apply machine learning to deliver clinical insights.
This Digital Surgery solution will enable the Company’s vision of
Performance-Guided Surgery.
LUNA, the Company’s Next Generation Digital Surgery
Platform
Designed based on the feedback received from over 10,000 digital
laparoscopic procedures performed with the Senhance System, the
LUNA Surgical System is the Company’s next generation digital
surgery platform. Through a combination of advanced minimally
invasive instrumentation, the first ever digital interface between
the surgeon and the console, and industry-leading clinical
intelligence tools, we believe LUNA is poised to revolutionize the
way surgery is performed.
The LUNA Surgical System is under development, and not currently
available for use.
The LUNA Surgical System is Asensus’ next
generation digital surgery platform that is poised to revolutionize
the way surgery is performed.
New Intelligent Surgical Unit Capabilities
Announced
The Company’s digital surgical platforms are powered by the ISU.
The ISU enables real-time surgical image analytics coupled with
machine vision-driven control of the camera for a surgeon by
responding to commands and recognizing certain objects and
locations in the surgical field. It allows the surgeon to measure
anatomy, place digital tags, enhance the surgical image and offers
Augmented Intelligence (AI) driven control of the camera enabling
the surgeon to focus on other critical surgical tasks.
The Company is announcing incremental features sets which are
now under development:
- An Analytical Feature Set, which
includes pre-operative surgical planning that will allow surgeons
to map out and plan for specific surgical actions intraoperatively
using the ISU’s Augmented Intelligence
- A Safety Feature Set, which includes “no fly zone”
functionality that will enable the identification and marking of
potential hazards during the operation, thereby restricting
instruments from entering into defined anatomical structures
- A Training and Education Set, which
includes telestration, allowing multiple team members to work
together in real-time by annotating, highlighting and drawing on a
shared visual display of the surgical field
Cloud Data Architecture and Machine
Learning
Asensus Surgical previously announced that it agreed on a
multi-year strategic collaboration with Google Cloud to integrate
Google Cloud’s secure cloud data architecture and machine learning
technologies to further expand the capabilities of the Asensus
Surgical’s Performance-Guided Surgery framework enabled through the
ISU. Google’s secure cloud data architecture will capture this data
and Asensus will enable customer access portals and performance
dashboards for surgeons and hospitals. Google’s machine learning
technologies will be utilized to analyze the data and discern
clinical intelligence that can be utilized by surgeons and
hospitals in addition to continuously improving the software in the
ISU to provide better intra-operative clinical insight. This
collaboration to better capture clinical performance data and apply
Augmented Intelligence capabilities is expected to provide clinical
insight and drive superior outcomes for patients.
KARL STORZ Collaboration Agreement
The Company previously announced that it had entered into a
Memorandum of Understanding with KARL STORZ VentureONE Pte. Ltd.
(KARL STORZ), a new wholly owned subsidiary of KARL STORZ SE &
Co. KG, a global leader in the medical technologies industry,
especially in the area of endoscopes, medical instruments, and
devices that offers state-of-the-art technology for minimally
invasive procedures in virtually all surgical specialties. As part
of this agreement, KARL STORZ intends to market and sell Asensus’
Intelligent Surgical Unit as a standalone device together with
their IMAGE1 S™ Imaging system and OR1™ integration solution. The
companies also intend to work together on the integration of the
ISU into KARL STORZ's laparoscopic vision systems and jointly
collaborate on developing next-generation instrumentation to be
used with Asensus and KARL STORZ surgical platforms. As a
solution-oriented and innovative partner, KARL STORZ is in close
collaboration with surgeons and health care partners around the
globe to enable them to perform at their very best every day to
improve patients' lives. Upon finalization of the definitive
agreements, the ISU’s will bring its advanced Augmented
Intelligence capabilities to operating rooms around the world.
February 2023 Investor Day
The Company is hosting an Investor Day today, Tuesday, February
21, 2023 in New York, NY. The event will begin at 11:30 AM EST. A
live webcast of the conference presentation will be available
online on the investor relations page of the Company’s website at
https://ir.asensus.com/events-and-presentations. Replays of the
webcasts will be archived on the website.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the
surgeon and patient to pioneer a new era of Performance-Guided
Surgery by unlocking clinical intelligence for surgeons to enable
consistently superior outcomes and a new standard of surgery. Based
upon the foundation of Digital Laparoscopy with the Senhance
Surgical System, the Company is developing the LUNA Surgical
System, a next generation robotic and instrument system as a
foundation of its Digital Surgery solution. These systems will be
powered by the Intelligent Surgical Unit to increase surgeon
control and reduce surgical variability. With the addition of
machine vision, Augmented Intelligence, and deep learning
capabilities throughout the surgical experience, we intend to
holistically address the current clinical, cognitive and economic
shortcomings that drive surgical outcomes and value-based
healthcare. The Senhance Surgical System is now available for sale
in the US, EU, Japan, Russia, and select other countries. For a
complete list of indications for use, visit:
www.senhance.com/indications. To learn more about
Performance-Guided Surgery, Digital Laparoscopy with the Senhance
Surgical System and the new LUNA System visit www.asensus.com.
Follow Asensus
Email Alerts: https://ir.asensus.com/email-alerts
LinkedIn:
https://www.linkedin.com/company/asensus-surgical-inc
Twitter: https://twitter.com/AsensusSurgical
YouTube: https://www.youtube.com/c/transenterix
Vimeo: https://vimeo.com/asxc
Forward-Looking Statements
This press release includes statements relating to Asensus
Surgical and its corporate update. These statements and other
statements regarding our future plans and goals constitute "forward
looking statements'' within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934, and are intended to qualify for the safe harbor from
liability established by the Private Securities Litigation Reform
Act of 1995. Such statements are subject to risks and uncertainties
that are often difficult to predict, are beyond our control and
which may cause results to differ materially from expectations and
include whether Asensus Surgical will be able to successfully
develop its LUNA Surgical System, whether Asensus Surgical’s
Digital solution will enable its vision of Performance-Guided
Surgery, whether the LUNA Surgical System will revolutionize the
way surgery is performed, whether the incremental features sets
under development for the ISU will be successful, whether the
collaboration between Asensus Surgical and Google Cloud will be
successful and whether definitive agreements will be successfully
negotiated and lead to a successful collaboration between Asensus
Surgical and Karl Storz. For a discussion of the risks and
uncertainties associated with the Company’s business, please review
our filings with the Securities and Exchange Commission (SEC),
including our Annual Report on Form 10-K for the year ended
December 31, 2021, filed with the SEC on February 28, 2022 and our
other filings we make with the SEC. You are cautioned not to place
undue reliance on these forward looking statements, which are based
on our expectations as of the date of this press release and speak
only as of the origination date of this press release. We undertake
no obligation to publicly update or revise any forward-looking
statement, whether as a result of new information, future events or
otherwise.
INVESTOR CONTACT:
Mark Klausner or Mike Vallie, 443-213-0499
invest@asensus.com
MEDIA CONTACT:
Isabella Rodriguez, 708-833-1572
CG Life
irodriguez@cglife.com
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/2a09de6b-eb1e-4cb2-a353-81d26269ba57
Asensus Surgical (AMEX:ASXC)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Asensus Surgical (AMEX:ASXC)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024